Ozempic® & Semaglutide Lawsuits Are Happening Right Now
We Are Fighting For You
Maddox & Cisneros, PLLC, is actively investigating and placing claims on behalf of patients and individuals who suffered severe gastrointestinal damages and related complications after using Ozempic®, Wegovy®, Rybelsus®, Mounjaro®, Trulicity®, Jardiance®, and other semaglutide (GLP‑1) drugs.
Plaintiffs across the country and worldwide are claiming that drug manufacturers, distributors, physicians, marketers, and others failed to adequately warn people about the risks.
Additionally, whether you’re a patient or an attorney searching for co-counsel to litigate individual cases or facilitate class action,
People are suffering debilitating symptoms
Many of them long‑term, permanent, and irreparably damaging to stomachs, intestines, gallbladders, and other organs.
- Health
- Quality of life
- Careers
- Abilities
- Relationships
- And futures
HAVE BEEN COMPROMISED!
When you or a loved one is having serious digestive problems, vision changes, or any other complications after taking these medications, you should check with an attorney. You might be able to participate in emerging Ozempic® and GLP‑1 multidistrict litigations (MDL). That means your case and similar ones could go before one judge for more efficient pretrial proceedings. MDL consolidates discovery and motions to reduce costs, better avoid inconsistent rulings, and can often lead to settlement via representatives.
The Damages Claimants Are Alleging
- The drugs cause severe gastrointestinal injuries, including gastroparesis (stomach paralysis), ileus, and bowel obstruction.
- Manufacturers knew or should have known, from clinical data and adverse event reports, that these risks were serious and potentially permanent.
- Drug labeling and marketing downplayed or omitted the dangers that routine “GI side effects” could progress into debilitating conditions requiring hospitalization, surgery, and/or long‑term care.
- Patients and prescribers were not adequately warned, and many individuals would have chosen different therapies or more closely monitored what was going on had they known the true information.
Common Injuries and Symptoms Linked to Semaglutide
Gastrointestinal complications
- Gastroparesis (stomach paralysis) – delayed or stopped stomach emptying leading to chronic nausea, vomiting, abdominal pain, rapid fullness after only a few bites, bloating, malnutrition, and severe dehydration.
- Ileus and intestinal obstruction / blockage – impaired or stopped movement of food or waste through the intestines, sometimes requiring emergency hospitalization, NG tubes, or surgery.
- Persistent gastroenteritis and severe GI inflammation – repeated bouts of vomiting, diarrhea, abdominal cramping, and pain, often lasting weeks or months beyond normal “adjustment” to side effects.
- Reflux and abdominal distress – acid reflux, abdominal fullness, cramping, and swelling, including episodes of vomiting undigested food eaten hours earlier.
Organ and systemic injuries
- Gallbladder disease and gallstones, sometimes leading to gallbladder removal or biliary obstruction.
- Severe dehydration and acute kidney injury tied to uncontrolled vomiting and diarrhea.
- Pancreatitis, including severe or even hemorrhagic/necrotizing forms, now reflected in updated warning language.
Psychological and body‑image effects
- Body dysmorphia and eating disorder from dramatic, drug‑driven appetite suppression, rapid weight loss, and distorted self‑perception, often extreme and unintended.
- Anxiety, social withdrawal, or shame stemming from chronic vomiting, GI distress, and sudden physical changes.
Vision and neurological concerns
- Vision loss and NAION (non‑arteritic anterior ischemic optic neuropathy) – some claims allege semaglutide drugs increase the risk of sudden, sometimes permanent, vision loss in one or both eyes, often due to restricted blood supply.
Do You Qualify for an Ozempic® or Semaglutide Case?
- You used Ozempic®, Wegovy®, Rybelsus®, Mounjaro®, Trulicity®, Jardiance®, or another semaglutide/GLP‑1 drug.
- You were later diagnosed with gastroparesis, ileus, intestinal obstruction, severe gastroenteritis, gallbladder injury, pancreatitis, or another serious GI‑related complication.
- Your symptoms lasted longer than expected for an adjustment period. Forr example, persistent vomiting for four weeks or more, repeated hospital or ER visits, or surgical intervention.
- Your healthcare providers linked, suspected, or evaluated a connection between your condition and the use of semaglutide.
Maddox & Cisneros, PLLC, will evaluate your
Medical records, including imaging and GI testing
Prescription history
Healthcare timelines
The conduct of medical professionals
How injuries affect your employment, daily functioning, and quality of life
You do not need to know whether your case fits into a specific multidistrict litigation (MDL) or state‑court proceeding before calling us. We will figure that out for you and see what you would prefer. Our attorneys handle MDL filings, individual lawsuits, and referrals to appropriate jurisdictions as the litigation evolves.
Potential Damages in Ozempic® and Semaglutide Litigation
- Past and future medical expenses, including hospitalizations, GI procedures, medications, and long‑term follow‑up.
- Lost wages, diminished earning capacity, and interrupted career or household responsibilities.
- Physical pain, ongoing gastrointestinal discomfort, nausea, and fatigue.
- Emotional distress, anxiety, body dysmorphia, and loss of enjoyment of life.
- In appropriate cases, punitive damages to punish and deter wrongful conduct by drug manufacturers.
DO NOT WAIT. ACT NOW.
Now is the time to act if you are a patient, a family member, or an attorney with a potential GLP‑1 injury case. When you wait too long statutes of limitation and filing deadlines waste otherwise valid claims. Cases are being filed nationwide.
- Past and future medical expenses, including hospitalizations, GI procedures, medications, and long‑term follow‑up.
- Call Maddox & Cisneros, PLLC, today at 702.366-1900 for a FREE confidential case evaluation.
- Click here to Contact Us
- Submit our secure online intake form and indicate that you used Ozempic®, Wegovy®, Rybelsus®, Mounjaro®, Trulicity®, Jardiance®, or another semaglutide drug.
You pay no legal fees until we recover for you.
Here’s what courts typically look for in allowing class action cases
Numerosity
Enough people are affected to make a class action lawsuit practical. This number might range between a few dozen up to thousands.
Commonality
Everyone’s claims are rooted in the same legal issues and facts. These issues might be about the same defective products, policies, fees, misrepresentations, or damages.
Typicality
The proposed class or group of people are representative of the same situation as the rest of the people in the group. The same kind of harm happened for the same reasons.
Adequate Representation
The plaintiffs and their lawyers for the group are able to fairly and adequately protect the interests of the entire class or group of people.
When these conditions are met, a court is more likely to “certify” the class so the case can proceed on a group basis.
Class Action Settlements
$11,400,000
$251,000,000-$338,900,00
$493,000,000
$98,500,000
$1,230,000
$2,100,000
$275,900,000